BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinast V, Burkard TL, Todt D, Steinmann E. Hepatitis E Virus Drug Development. Viruses. 2019;11. [PMID: 31141919 DOI: 10.3390/v11060485] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tietcheu Galani BR, Ayissi Owona VB, Guemmogne Temdie RJ, Metzger K, Atsama Amougou M, Djamen Chuisseu PD, Fondjo Kouam A, Ngounoue Djuidje M, Aliouat-Denis CM, Cocquerel L, Fewou Moundipa P. In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus. In Silico Pharmacol 2021;9:35. [PMID: 33959472 DOI: 10.1007/s40203-021-00093-y] [Reference Citation Analysis]
2 Carter M, Solsrud K, Yeddula S, Fitzmaurice MG, Singh A, Nagai S, Jafri SM. Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single-Center Experience. Transplant Proc 2022:S0041-1345(22)00438-9. [PMID: 35907694 DOI: 10.1016/j.transproceed.2022.04.025] [Reference Citation Analysis]
3 Zhang C, Freistaedter A, Schmelas C, Gunkel M, Dao Thi VL, Grimm D. An RNA Interference/Adeno-Associated Virus Vector-Based Combinatorial Gene Therapy Approach Against Hepatitis E Virus. Hepatol Commun 2021. [PMID: 34719133 DOI: 10.1002/hep4.1842] [Reference Citation Analysis]
4 Colson P, Decoster C. Recent data on hepatitis E. Curr Opin Infect Dis 2019;32:475-81. [PMID: 31361659 DOI: 10.1097/QCO.0000000000000590] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Todt D, Friesland M, Moeller N, Praditya D, Kinast V, Brüggemann Y, Knegendorf L, Burkard T, Steinmann J, Burm R, Verhoye L, Wahid A, Meister TL, Engelmann M, Pfankuche VM, Puff C, Vondran FWR, Baumgärtner W, Meuleman P, Behrendt P, Steinmann E. Robust hepatitis E virus infection and transcriptional response in human hepatocytes. Proc Natl Acad Sci U S A 2020;117:1731-41. [PMID: 31896581 DOI: 10.1073/pnas.1912307117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
6 Wu C, Wu X, Xia J. Hepatitis E virus infection during pregnancy. Virol J 2020;17:73. [PMID: 32522266 DOI: 10.1186/s12985-020-01343-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
7 Sayed IM, Meuleman P. Updates in Hepatitis E virus (HEV) field; lessons learned from human liver chimeric mice. Rev Med Virol 2020;30:e2086. [PMID: 31835277 DOI: 10.1002/rmv.2086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
8 Fu RM, Decker CC, Dao Thi VL. Cell Culture Models for Hepatitis E Virus. Viruses 2019;11:E608. [PMID: 31277308 DOI: 10.3390/v11070608] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
9 Yadav KK, Boley PA, Fritts Z, Kenney SP. Ectopic Expression of Genotype 1 Hepatitis E Virus ORF4 Increases Genotype 3 HEV Viral Replication in Cell Culture. Viruses 2021;13:75. [PMID: 33430442 DOI: 10.3390/v13010075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Wißing MH, Brüggemann Y, Steinmann E, Todt D. Virus-Host Cell Interplay during Hepatitis E Virus Infection. Trends Microbiol 2021;29:309-19. [PMID: 32828646 DOI: 10.1016/j.tim.2020.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
11 Torre P, Aglitti A, Masarone M, Persico M. Viral hepatitis: Milestones, unresolved issues, and future goals. World J Gastroenterol 2021; 27(28): 4603-4638 [PMID: 34366625 DOI: 10.3748/wjg.v27.i28.4603] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
12 Chaudhary M, Nain V, Sehgal D. Molecular docking and dynamic simulation analysis of Hepatitis E virus protease in complexing with the E64 inhibitor. J Biomol Struct Dyn 2021;:1-9. [PMID: 34931595 DOI: 10.1080/07391102.2021.2019124] [Reference Citation Analysis]
13 Chilaka VN, Konje JC. Viral Hepatitis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2021;256:287-96. [PMID: 33259998 DOI: 10.1016/j.ejogrb.2020.11.052] [Reference Citation Analysis]
14 Burkard T, Proske N, Resner K, Collignon L, Knegendorf L, Friesland M, Verhoye L, Sayed IM, Brüggemann Y, Nocke MK, Behrendt P, Wedemeyer H, Meuleman P, Todt D, Steinmann E. Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems. Cells 2022;11:927. [PMID: 35326378 DOI: 10.3390/cells11060927] [Reference Citation Analysis]
15 Ahmed Z, Shetty A, Victor DW, Kodali S. Viral hepatitis: A narrative review of hepatitis A–E. World J Meta-Anal 2022; 10(3): 99-121 [DOI: 10.13105/wjma.v10.i3.99] [Reference Citation Analysis]
16 Nishiyama T, Kobayashi T, Jirintai S, Nagashima S, Primadharsini PP, Nishizawa T, Okamoto H. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro. Antiviral Res. 2019;170:104570. [PMID: 31362004 DOI: 10.1016/j.antiviral.2019.104570] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hajeri PB, Sharma NS, Yamamoto M. Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity. Cancers (Basel) 2020;12:E1504. [PMID: 32526919 DOI: 10.3390/cancers12061504] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]